Managed all financial aspects of research for multiple disease areas with a major focus on Cardiovascular, Gastroenterology, Haematology, Neurology and Trauma & Orthopaedics. Supported Clinicians, Senior Nursing and Study Support with all aspects of budgetary control, forecasting and research applications. Developed a suite of internal guidelines as to how things work in the Trust. Key contact for all things commercial interfacing with both sponsors and funders

Played a key role in the Programme Management Office (PMO), providing supporting financial and non-financial analysis to a wide range of tasks, including financial performance management, Trust-wide reporting, dedicated improvement projects and business case development. Assisted the PMO Transformation Team where necessary in the analysis of benchmarking and performance information to identify opportunities for improvement and ensuring organisational agreement.

Ward-based (extended) interim business development role focused on increasing the awareness of the Acer ward nationally. Remit also includes the development of a communication and social media strategy and associated metrics. Designed, developed and implemented a pricing model to better capture underlying ward activity. Doubled “out of area” revenues against a backdrop of significant local authority budget cuts.

Extended interim role focused on establishing a new costing and pricing team at the Trust to better support Divisional activity and 3rd Party negotiation. Remit also includes system and business development, and embedding “hub and spoke” principle to business areas; increasing intensity of relationships across the Joint Research Office and with Chief/Principle Investigators. Designed, developed and implemented a costing and pricing system to capture all R&D activity for the Trust.

Extended interim role to provide strategic pricing and market access consulting for a leading medical device company. Developed new commercial model to foster better partnership with NHS England. Prepared business case for new product entry with a leading NHS Trust. Reviewed PBR and PLICS reporting for Cardiology.

Provided physical and emotional support to aged parent.

Achieved a lifetime ambition to tour the country and participate in the Rugby World Cup.

First time passes in both Foundation and Practitioner.PRINCE2 is a process-based approach for project management, providing an easily tailored and scaleable project management methodology for the management of all types of projects. The method is the de-facto standard for project management in the UK and is practiced worldwide.

Directed the Finance organisation for UK and Ireland (Commercial, Medical and Clinical Development). FP&A. Ensured that financial targets were exceeded, and that resources were used in the best way to deliver the objectives outlined by the organisation. Analysed and identified risks and opportunities. Prepared and implemented the strategic, annual and operating plans.Delivered significant benefits in terms of improving: process efficiency; effectiveness and control in a matrix organisation (UK, EMEA and Global). Increased usage and reputation of offshore shared service centre.Led commercial, pricing and supply chain activities to focus on patient demand in the UK.Business leader for all activities in relation to business continuity planning, procurement of key services and IM strategy. Shaped and realised Pharmaceutical Price Regulation Scheme (PPRS) delivery in the UK; led the development of innovative pricing strategies with key accounts. Identified key business drivers, market dynamics and options to take the business forward.Drove the development of sales objectives at national and territory level. Provided financial direction for 6 on-market brands. Promoted good business ethics. Professionally applied, trained and monitored standards in a rigorous, ethical and consistent way so that systems, processes and people ensured integrity and reliability of business plans and underlying business performance.Achievements:Managed: Against a background of mandatory price cuts, led a review of price elasticity in the UK market with Brand Teams that delivered a pricing strategy that ensured double digit sales growth over a period of two years. Coordinated cross functional activities: Successfully developed and implemented commercial and supply chain strategies in the Oncology Business Unit to ensure supply of product to UK patients; realising an increase of > M 5 USD to the Novartis Group.

Established and successfully led business transformation project. Engaged employees and stakeholder in understanding the rational of the Turnaround Plan and their role its implementation. Provided financial insight and fact-based analysis to support decision making.Formulated a clear strategy for Business Development, Risk Management, Information Management and Business Planning in a shared services environment across the School.Achievements:Improved efficiency and organisational effectiveness: Coached Principal to communicate with authority and confidence to people at all levels, and to motivate teams to turn them into high performing and highly motivated units. Developed new Senior Leadership Team structure and way forward for the Business.

Led / Co-Led core initiatives in the Development organization. Created and established benchmarking activities, both internally and externally, and portfolio management activities. Represented Development function at all major industry benchmarking forums.Evaluated insourcing/outsourcing options including transaction support and on-going relationship improvement.Worked with the business to ensure accurate forecasting and budgeting of business performance.Delivered competitive intelligence platform and dashboard for Clinical Development and Pharma CEO.Assisted Investor Relations with quarterly and annual reviews.Undertook diagnostic exercises to understand the 'health' of the Clinical Development function; specifically identified what was required to address current and foreseen challenges and changes in the business landscape.Supported Brand Teams in the financial evaluation of products in development. Ensured robustness of business proposals, with a focus on forecasting, risk assessment and return on investment calculations. Critically challenged thinking/analysis to ensure business awareness to implement integrated marketing launch plans.

Led Finance function for the Lifecycle organization. Member of the Lifecycle Committee (Roche’s senior late stage project committee). Undertook business reviews and projects, including cash flow improvement and business restructuring.Key interface between Finance and 20+ Brand Teams, with a focus on driving growth and profitability, building quarterly forecasting and annual plans, whilst overseeing performance against marketing and promotional budgets.Ensured clear support and commitment behind changes. Initiated and drove significant changes to processes, contracts and systems to address underlying performance issues and employee engagement.FP&A. Continuously improved financial planning cycle linked to strategic objectives. Implemented best practice internal financial controls. Critically assessed new challenges that threatened improvement initiatives.Performed both analytical “pre-deal” due diligence and confirmatory due diligence. Led financial management of all projects post discovery through market approval, and the financial relationship with 3rd party CFOs. Produced accurate monthly monitoring reports combining financial and performance data for Board Members, Senior Leadership and Brand Teams. Created, implemented, and enforced policies and procedures. Designed and developed systems (ERP) for monitoring and reporting performance against agreed KPIs.Increased department performance by coaching and developing the team to become true business partners. Counselled and developed financial talent, guiding them through their careers both within finance and the larger organisation.

Re-shaped the future of the Pharmaceutical Division which improved sales and profitability. Established, implemented, and drove improvement measures that cut $ 300 million p.a. of cost. Increased partnership with Research Strategic Marketing to achieve better candidate selection. Streamlined organization; including closing sites. Resourced high-priority projects that offered greatest value potential.

Led Finance function for the Palo Alto organization (250 personnel, Budget > M 100 USD).Core member of the Palo Alto Leadership Team and Site and Financial Services Team. FP&A. Integrated new organizational unit into global organization. Prepared budgets, forecasts and period reporting, together with monitoring KPI and scorecard metrics to judge performance. Ensured business plans were aligned with the organizational capabilities of the business. Managed transition projects through to successful delivery.Designed development and roll out of enterprise wide financial systems and analytics (ERP).Managed financial relationship with outsourcing partners; completed commercial review of all 3rd party contracts.

Established and integrated major new financial Performance Management Programmes.Developed and rolled out quarterly reporting for the Pharmaceutical Division.Integrated Boehringer Mannheim and Syntex following acquisition of the companies.Co-ordinated and defined Pharma consolidation requirements. Prepared decision support financials for Business Partners and Senior Management.

Analysed and interpreted quantitative and qualitative reporting submitted by the affiliates, to ensure compliance with the approved Divisional strategies, objectives and plans. Studied affiliates’ performance in order to proactively identify potential issues and recommend corrective actions to senior Divisional Management.Conducted the financial assessment of investment, divestment, and strategic alliance proposals submitted by the affiliates.Ensured, in cooperation with the relevant Therapeutic Areas, that product launch plans submitted by the affiliates complied with the Divisional objectives, with specific focus on consolidated profitability and return on investments.

Managed key accounts of leading pharmaceutical companies.Developed industry scenarios. Contributed to and executed a strategy for business growth.Evaluated pricing strategies and customer specific activities.Rolled out internal conflict resolution processes. Strived to achieve the best possible outcomes in all situations. Drove changes to systems, processes and practises to improve the long-term service offered.Championed the needs of customers and members across the organisation. Made a strong business case behind proposals, weighing up costs, benefits, risks, issues and return on investments. Translated big ideas and visions into viable long-term implementation and change programmes.

Consolidated all financial activities in Europe, Middle East and Africa. Developed and produced monthly management board performance review packs providing improved scrutiny of business performance and key business initiatives.Streamlined business that included site closure activities. Led profit protection planning and analysis. FP&A. Integrated global financial strategies and process changes. Orchestrated strategic financial planning, budgeting and financial analysis processes working cross-functionally with Regions & Business Unit Heads.

FP&A. Established an effective Performance Management System. Led the annual budgeting review and analysis process. Worked with the business to ensure accurate forecasting and budgeting of business performance.Designed robust financial systems and KPIs. Established, maintained and developed financial controls to Group standards across the business.Successfully improved internal controls and audit. Ensured DSO remained in line within agreed payment terms and corporate targets. Interacted with Operations on inventory controls; monitored and improved DOI.

Controlled material costing, payroll, purchase ledger and stock ledger.Created and rolled out standard cost modules. Managed BOM changes, stock adjustments and purchase price variances.Prepared and implemented strategic plans and latest outlook reviews. Trained senior managers, subordinates and newcomers in system applications.